Article Versions Notes

Starvaggi J, Di Chio C, Lang J, Belgiovine V, Trisciuzzi D, Previti S, Klein C, Nicolotti O, Di Maro S, Zappalà M, et al. Development of Novel Proline- and Pipecolic Acid-Based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease. Pharmaceuticals. 2026; 19(1):24. https://doi.org/10.3390/ph19010024

Starvaggi, Josè, Carla Di Chio, Johannes Lang, Valentina Belgiovine, Daniela Trisciuzzi, Santo Previti, Christian Klein, Orazio Nicolotti, Salvatore Di Maro, Maria Zappalà, and et al. 2026. "Development of Novel Proline- and Pipecolic Acid-Based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease" Pharmaceuticals 19, no. 1: 24. https://doi.org/10.3390/ph19010024

Starvaggi, J., Di Chio, C., Lang, J., Belgiovine, V., Trisciuzzi, D., Previti, S., Klein, C., Nicolotti, O., Di Maro, S., Zappalà, M., & Ettari, R. (2026). Development of Novel Proline- and Pipecolic Acid-Based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease. Pharmaceuticals, 19(1), 24. https://doi.org/10.3390/ph19010024